Defining the Role of CD2 in Disease Progression and Overall Survival among Patients with Resectable Primary Melanoma

P-024

  • Harcharik, S.
  • Moskalenko, M.
  • Pan, M.
  • Bernardo, S.
  • Sivendran, M.
  • Bell, H.
  • Sivendran, S.
  • Saenger, Y.
  • Phelps, R.

  • 1Dermatology, Mount Sinai Medical Center, NY, USA;

    2Mount Sinai Medical Center, Hematology/Medical Oncology, NY, USA;

    3Dermatology, Geisinger Medical Center, Danville, USA;

    4Pathology, Mount Sinai Medical Center, NY, USA;

    5Hematology/Oncology Medical Specialists, Lancaster General Health, Lancaster, USA;

    6Dermatology, Mount Sinai Medical Center, Hematology/Medical Oncology, NY, USA and;

    7Dermatology, Mount Sinai Medical Center, Pathology, NY, USA

Journal der Deutschen Dermatologischen Gesellschaft 11:p 31-32, July 2013.
Copyright © 2013 Blackwell Publishing Ltd.